Monoclonal antibodies in cancer therapy. Journal of Clinical Oncology. 1983; 1: 582-590 Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs. Acc Chem Res. 2008; 41: 98-107 Pegram M.D. Pauletti G. Slamon D.J. Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy. Breast Cancer Res Treat. 1998; 52: 65-77 Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer. New England Journal of Medicine.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile